Table 2.

Molecular results and characteristics of patients with other liver tumors

Patient	Liver disease/primary cancer	Non-tumor tissue				Tumor tissue
		Fibrosis score (Ishak et al. 1995)	Methylight analysis		Differentiation (MacSween et al. 2002)	Methylight analysis
			Result	PMR (%)		Result	PMR (%)
Cholangiocellular carcinoma (CCC)
Case number
CCC1	Bile duct	6	Negative	2.57	G2	Negative	0
CCC2	Bile duct	0	Positive	21.74	G3	Negative	0
CCC3	Bile duct	2	Positive	5.82	G3	Negative	0
CCC4	Bile duct	0	Positive	16.97	G2	Positive	5.38
CCC5	Bile duct	0	Positive	24.38	G2	Negative	0
CCC6	Gall baldder	1	Negative	0	G1	Negative	0
CCC7	Gall bladder	0	Negative	0	G2	Negative	0
Liver metastasis (M)
Case number
M1	Breast	0	Positive	9.54	G2	Negative	0
M2	Colorectal	0	Positive	27.38	G2	Negative	0
M3	Colorectal	0	Positive	40.77	G3	Negative	0
M4	Colorectal	0	Positive	26.26	G3	Negative	0
M5	Nephroblastoma	0	Positive	6.71	G2	Negative	0
M6	Colorectal	0	Positive	20.91	G3	Positive	6.36
M7	Colorectal	4	Positive	5.46	G2	Negative	0
M8	Colorectal	0	Positive	18.23	G2	Negative	2.39
M9	Colorectal	0	Positive	45.51	G2	Positive	69.95
M10	Colorectal	0	Negative	0	G2	Positive	23.65
M11	Gastric	0	Positive	36.68	G3	Positive	23.74
M12	Colorectal	0	Positive	25.78	G2	Positive	21.65
M13	Colorectal	0	Positive	12.48	G2	Negative	0
M14	Colorectal	1	Positive	22.17	G2	Positive	27.73
M15	Colorectal	0	Positive	29.5	G2	Positive	57.92
M16	Colorectal	0	Positive	16.95	G2	Negative	0
M17	Breast	0	Positive	15.85	G2	Positive	30.51
M18	Colorectal	0	Positive	42.59	G3	Positive	21.44
M19	Colorectal	0	Negative	0	G2	Positive	7.57
Benign liver tumor (B)
Case number
B1	FNH	0	Negative	3.52	na	Positive	24.09
B2	FNH	0	Positive	42	na	Positive	69.82
B3	FNH	0	Positive	20.6	na	Positive	67.29
B4	FNH	0	Positive	27.96	na	Positive	15.24
B5	Hepatic adenoma	0	Positive	30.13	na	Positive	79.45

FNH focal nodular hyperplasia